These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 22683651
1. Design and evaluation of inhalable chitosan-modified poly (DL-lactic-co-glycolic acid) nanocomposite particles. Yang M, Yamamoto H, Kurashima H, Takeuchi H, Yokoyama T, Tsujimoto H, Kawashima Y. Eur J Pharm Sci; 2012 Aug 30; 47(1):235-43. PubMed ID: 22683651 [Abstract] [Full Text] [Related]
2. Design and evaluation of poly(DL-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation. Yang M, Yamamoto H, Kurashima H, Takeuchi H, Yokoyama T, Tsujimoto H, Kawashima Y. Eur J Pharm Sci; 2012 Aug 15; 46(5):374-80. PubMed ID: 22414702 [Abstract] [Full Text] [Related]
3. Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer. Tomoda K, Ohkoshi T, Hirota K, Sonavane GS, Nakajima T, Terada H, Komuro M, Kitazato K, Makino K. Colloids Surf B Biointerfaces; 2009 Jul 01; 71(2):177-82. PubMed ID: 19264458 [Abstract] [Full Text] [Related]
4. [Preparation and characterization of tetrandrine-loaded PLGA nanocomposite particles by premix membrane emulsification coupled with spray-drying method]. Hu T, Zhu HX, Guo LW, Pan LM, Li B, Shi FY, Lu J. Yao Xue Xue Bao; 2014 Nov 01; 49(11):1607-13. PubMed ID: 25757290 [Abstract] [Full Text] [Related]
5. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery. Sinsuebpol C, Chatchawalsaisin J, Kulvanich P. Drug Des Devel Ther; 2013 Nov 01; 7():861-73. PubMed ID: 24039397 [Abstract] [Full Text] [Related]
6. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. Yamamoto H, Kuno Y, Sugimoto S, Takeuchi H, Kawashima Y. J Control Release; 2005 Feb 02; 102(2):373-81. PubMed ID: 15653158 [Abstract] [Full Text] [Related]
7. Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA. Jensen DK, Jensen LB, Koocheki S, Bengtson L, Cun D, Nielsen HM, Foged C. J Control Release; 2012 Jan 10; 157(1):141-8. PubMed ID: 21864597 [Abstract] [Full Text] [Related]
8. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles. Lee C, Seo J, Hwang HS, Thao LQ, Lee S, Lee ES, Lee EH, Choi HG, Youn YS. Biomed Pharmacother; 2016 Mar 10; 78():226-233. PubMed ID: 26898446 [Abstract] [Full Text] [Related]
9. Preparation and properties of inhalable nanocomposite particles: effects of the temperature at a spray-dryer inlet upon the properties of particles. Tomoda K, Ohkoshi T, Kawai Y, Nishiwaki M, Nakajima T, Makino K. Colloids Surf B Biointerfaces; 2008 Feb 15; 61(2):138-44. PubMed ID: 17890065 [Abstract] [Full Text] [Related]
10. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency. Lee SY, Jung E, Park JH, Park JW, Shim CK, Kim DD, Yoon IS, Cho HJ. J Colloid Interface Sci; 2016 Oct 15; 480():102-108. PubMed ID: 27421112 [Abstract] [Full Text] [Related]
11. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers. Ungaro F, d'Angelo I, Coletta C, d'Emmanuele di Villa Bianca R, Sorrentino R, Perfetto B, Tufano MA, Miro A, La Rotonda MI, Quaglia F. J Control Release; 2012 Jan 10; 157(1):149-59. PubMed ID: 21864595 [Abstract] [Full Text] [Related]
12. Preparation and properties of inhalable nanocomposite particles: effects of the size, weight ratio of the primary nanoparticles in nanocomposite particles and temperature at a spray-dryer inlet upon properties of nanocomposite particles. Tomoda K, Ohkoshi T, Nakajima T, Makino K. Colloids Surf B Biointerfaces; 2008 Jun 15; 64(1):70-6. PubMed ID: 18343097 [Abstract] [Full Text] [Related]
13. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes. Lee C, Choi JS, Kim I, Oh KT, Lee ES, Park ES, Lee KC, Youn YS. Int J Nanomedicine; 2013 Jun 15; 8():2975-83. PubMed ID: 23976850 [Abstract] [Full Text] [Related]
14. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X, Sun M, Zheng A, Cao D, Bi Y, Sun J. Eur J Pharm Sci; 2012 Apr 11; 45(5):632-8. PubMed ID: 22248882 [Abstract] [Full Text] [Related]
15. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate. Özcan I, Azizoğlu E, Senyiğit T, Özyazici M, Özer Ö. J Drug Target; 2013 Jul 11; 21(6):542-50. PubMed ID: 23390922 [Abstract] [Full Text] [Related]
16. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles. Yang Y, Xie XY, Mei XG. Drug Deliv; 2016 Jul 11; 23(3):787-93. PubMed ID: 24870204 [Abstract] [Full Text] [Related]
17. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. Ohashi K, Kabasawa T, Ozeki T, Okada H. J Control Release; 2009 Apr 02; 135(1):19-24. PubMed ID: 19121349 [Abstract] [Full Text] [Related]
18. Design and Characterizations of Inhalable Poly(lactic-co-glycolic acid) Microspheres Prepared by the Fine Droplet Drying Process for a Sustained Effect of Salmon Calcitonin. Sato H, Tabata A, Moritani T, Morinaga T, Mizumoto T, Seto Y, Onoue S. Molecules; 2020 Mar 13; 25(6):. PubMed ID: 32183032 [Abstract] [Full Text] [Related]
19. Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days. Navarro SM, Darensbourg C, Cross L, Stout R, Coulon D, Astete CE, Morgan T, Sabliov CM. Ther Deliv; 2014 Nov 13; 5(11):1191-201. PubMed ID: 25491670 [Abstract] [Full Text] [Related]
20. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin. Guo M, Rong WT, Hou J, Wang DF, Lu Y, Wang Y, Yu SQ, Xu Q. Nanotechnology; 2013 Jun 21; 24(24):245101. PubMed ID: 23702815 [Abstract] [Full Text] [Related] Page: [Next] [New Search]